Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

24
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
24
Cross-reactivity00:42

Cross-reactivity

33.8K
Overview
33.8K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.5K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aridity-related differences in soil elemental ratios reshape microbial functional traits across global biomes.

Nature communications·2026
Same author

In silico prioritization and cheminformatics identify structurally diverse small-molecule inhibitors of Lassa virus glycoprotein-mediated membrane fusion.

SLAS discovery : advancing life sciences R & D·2026
Same author

From "synthetic" to defined microbial communities for clearer terminology.

Nature communications·2026
Same author

Microbial diversity loss constrains plastic degradation in marine sediments.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Functional restructuring of the global soil microbiome under multiple stressors.

Nature communications·2026
Same author

The virus entry inhibitor ARN-75039 provides therapeutic protection against Lassa virus infection in guinea pigs.

Science translational medicine·2026
Same journal

Novel duck reovirus σC hijacks the mitochondrial COQ6-CoQ10 axis to drive NLRP3-dependent pyroptosis.

PLoS pathogens·2026
Same journal

Shiga toxin delivery in extracellular vesicles induces high mortality and severe kidney injury in a Gb3-dependent manner.

PLoS pathogens·2026
Same journal

G protein-coupled receptor SmGPCR9 interacts with neuropeptides and controls spermatogenesis in Schistosoma mansoni.

PLoS pathogens·2026
Same journal

The Bunyamwera orthobunyavirus Gc glycoprotein head and stalk drives an infectious virion assembly pathway specific for the insect host.

PLoS pathogens·2026
Same journal

The hidden costs of using media to mimic the hosts of Fusarium graminearum: An epigenetic perspectives.

PLoS pathogens·2026
Same journal

Japanese encephalitis virus hijacks the host purine biosynthetic network to promote viral replication in neurons.

PLoS pathogens·2026
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.5K

Interferon-γ Inhibits Ebola Virus Infection.

Bethany A Rhein1, Linda S Powers2, Kai Rogers1

  • 1Department of Microbiology, The University of Iowa, Iowa City, Iowa, United States of America.

Plos Pathogens
|November 13, 2015
PubMed
Summary
This summary is machine-generated.

Interferon gamma, an FDA-approved drug, shows promise in protecting against Ebola virus infection. This treatment significantly reduced illness and viral load in mice, suggesting a potential new therapy for filovirus outbreaks.

More Related Videos

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.6K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K

Related Experiment Videos

Last Updated: Mar 30, 2026

Rescue of Recombinant Newcastle Disease Virus from cDNA
10:55

Rescue of Recombinant Newcastle Disease Virus from cDNA

Published on: October 11, 2013

20.5K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.6K
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K

Area of Science:

  • Virology
  • Immunology
  • Drug Discovery

Background:

  • Ebola virus outbreaks are a significant global health threat with no currently available antiviral treatments.
  • Filoviruses, including Ebola virus, cause severe and often fatal hemorrhagic fevers.
  • Macrophages are identified as early cellular targets for Ebola virus infection.

Purpose of the Study:

  • To investigate the potential of interferon gamma as a prophylactic or therapeutic agent against Ebola virus infection.
  • To determine the mechanism by which interferon gamma inhibits Ebola virus replication.
  • To identify novel antiviral targets by examining interferon-stimulated genes.

Main Methods:

  • Administration of murine interferon gamma to mice challenged with mouse-adapted Ebola virus.
  • In vitro studies assessing the effect of interferon gamma on Ebola virus-infected macrophages.
  • Analysis of viral RNA levels and protein synthesis inhibition.
  • Microarray analysis of interferon gamma-treated human macrophages to identify interferon-stimulated genes.

Main Results:

  • Interferon gamma administration 24 hours before or after infection robustly protected mice from lethal Ebola virus challenge.
  • Treatment with interferon gamma significantly reduced morbidity and serum viral titers in infected mice.
  • Interferon gamma profoundly inhibited Ebola virus infection in macrophages, reducing viral RNA levels.
  • Studies suggest interferon gamma blocks virus replication, a process requiring protein synthesis.
  • Over 160 interferon-stimulated genes were identified, with some showing inhibitory effects on Ebola virus infection.

Conclusions:

  • Interferon gamma demonstrates significant prophylactic and therapeutic potential against Ebola virus infection.
  • The drug's mechanism involves inhibiting virus replication in macrophages, a key early target.
  • Identified interferon-stimulated genes offer new avenues for targeting negative-strand RNA viruses like Ebola.
  • Interferon gamma, being an FDA-approved drug, could be rapidly deployed for future filovirus outbreaks.